ANCA and associated diseases: immunodiagnostic and pathogenetic aspects.
about
Neurology of the vasculitides and connective tissue diseasesThe clinical utility of ANCA positivityLack of effect of antineutrophil cytoplasmic antibodies associated with ulcerative colitis on superoxide anion production from neutrophilsInvasive amoebiasis is associated with the development of anti-neutrophil cytoplasmic antibodyThe diversity of perinuclear antineutrophil cytoplasmic antibodies (pANCA) antigensPulmonary vasculitisAn audit of ANCA in routine clinical practiceDysregulation of autoantigen genes in ANCA-associated vasculitis involves alternative transcripts and new protein synthesisIdentification and validation of urinary biomarkers for differential diagnosis and evaluation of therapeutic intervention in anti-neutrophil cytoplasmic antibody-associated vasculitisGabexate mesylate as treatment in the course of ANCA-negative microscopic polyangiitis.Antineutrophil cytoplasmic antibodies and the eosinophilia myalgia syndrome.Minocycline induced arthritis associated with fever, livedo reticularis, and pANCAAntineutrophil cytoplasmic antibodies and the optic-spinal form of multiple sclerosis in Japan.Subacute bacterial endocarditis with positive cytoplasmic antineutrophil cytoplasmic antibodies and anti-proteinase 3 antibodies.Apoptosis in human autoimmune diseases.Small vessel vasculitis of the lungAutoantibodies associated with rheumatic diseases.Methods for the detection of anti-neutrophil cytoplasmic antibodies. Recommendations for clinical use of ANCA serology and laboratory efforts to optimize the informative value of ANCA test results.Antineutrophil cytoplasmic antibodies in sera from colectomised ulcerative colitis patients and its relation to the presence of pouchitisMyeloperoxidase-antineutrophil Cytoplasmic Antibodies with Cytoplasmic Fluorescence Pattern.Inflammatory cells and cellular activation in the lower respiratory tract in Churg-Strauss syndrome.Human autoantibody to defensin: disease association with hyperreactive onchocerciasis (sowda).Nuclear localization of the antigen detected by ulcerative colitis-associated perinuclear antineutrophil cytoplasmic antibodies.Antineutrophil cytoplasmic antibodies in myelodysplasiaMolecular characteristics of anti-self antibody fragments against neutrophil cytoplasmic antigens from human V gene phage display libraries.Antibodies with dual reactivity to plasminogen and complementary PR3 in PR3-ANCA vasculitis.ELISA is the superior method for detecting antineutrophil cytoplasmic antibodies in the diagnosis of systemic necrotising vasculitis.Clinical features and prognostic factors of Churg-Strauss syndrome.Pathogenesis of anti-neutrophil cytoplasmic antibody-associated vasculitis: challenges and solutions 2014.Increased expression of CTLA-4 (CD152) by T and B lymphocytes in Wegener's granulomatosis.Neutrophil cytoplasmic antibodies (p-ANCA) in ulcerative colitis.Formalin fixation and patterns of antineutrophil cytoplasmic antibodies.Antineutrophil cytoplasmic antibodies in chronic idiopathic intraocular inflammatory disease.Anti-neutrophil cytoplasmic antibodies in primary small vessel vasculitides.An adolescent with both Wegener's Granulomatosis and chronic blastomycosis.Hypertrophic pachymeningitis with anti-neutrophil cytoplasmic antibody (p-ANCA), and diabetes insipidus.Titre and affinity of propylthiouracil-induced anti-myeloperoxidase antibodies are closely associated with the development of clinical vasculitis.Calprotectin is raised in endogenous posterior uveitis.Anti-neutrophil cytoplasm autoantibodies (ANCA). The need for specific and sensitive assays.Unusual cerebral complication associated with ulcerative colitis.
P2860
Q24679901-35FDB4C0-1A05-4A2E-8765-7F3DC9D6A901Q27469302-C548AEB7-008D-48E6-9186-BBF769A1B40DQ27469322-0CC506EF-3C34-473D-BBB0-A5BACD4B3ACDQ27473448-1136CBFD-05AF-4FDF-BE46-6E8B104E2BA6Q27473538-4D91C051-0D44-405B-B750-1475B0E2EB2EQ27477901-1204CA65-445E-4120-AD64-3F30481DD2D0Q27486163-0303F2EB-1323-41A6-9185-034959E83FFDQ28386922-5A1BB098-DACF-4575-B2D9-1EB2E001A3BBQ30434677-EA36076D-6E07-466F-B1C0-D8BF8064912CQ33406896-F00C1CB0-F0F8-4A21-B42D-6D2A43239EB2Q33567150-D90FA724-33BB-45E6-B1DD-06F1135E1E16Q33579362-C301DEC2-9CA1-4A43-8572-A8B9B3C7413AQ33735494-F524DD3B-BE34-4115-A4EA-145FF006DE3FQ33822151-6C335EFA-1F3E-4F9C-99A7-4F090FDC62ECQ33836352-520C2934-78FD-4FA8-B0D5-63527D9447CAQ33922238-FBDCB6E1-46BA-4B51-8FA9-5AE575A3384FQ34249566-5BB28E00-9464-4111-8378-E3D9BDBB4D7CQ34395155-4F35D887-CAFE-4C24-958D-EB6CCF26D5A4Q34409834-76831759-AB70-4E85-8435-7B456C817987Q35138002-45EAC157-10A0-411F-BC98-C0CDBA4D8D21Q35533314-96010DCA-8F8A-4133-9A78-54D2FB6EC21EQ36365057-568D4A8E-2603-4150-9D46-2E73A4F5F7E1Q36683166-AE0A1F04-E741-4809-998F-D024FAF50269Q36751214-BDD899AB-C395-40D7-9A69-4CC72B3ABE64Q36788186-3728813D-CB14-41D3-945F-CC96C8DF701BQ36985746-2FAE6CCF-4846-41C5-A604-C524A0A3E0CDQ37240820-849902E2-A29F-459A-A9B2-5D4BAC1DF5FDQ37598833-2AFD01B8-DDC1-4EAB-BF26-AAA8F9BB0C24Q38300451-825B7978-07A9-4856-AEA6-A197DDAD273EQ39488916-2AF4810E-361B-410A-9DA9-0BA6D091620EQ39630344-27981CC9-645D-4CFC-B4CB-41A9B227383BQ39639674-EF2FCC6F-8122-4F9D-9B89-337CCDC433EEQ40952871-D8A7728D-9CAB-40B4-A3BC-7AAFED9F33F7Q40978265-61551360-5B30-4823-BB30-AD446FD78D31Q42401842-9A458FBE-57A4-4EE2-A7BA-B5C336804FD0Q43923063-F433A3E2-672B-4063-BAF3-78446AB76BD0Q46716284-E0C04923-F290-4589-A7A8-9A1040B2C100Q47742035-ECAC30B5-86F9-4758-B4AA-262760659790Q47984582-3AA2B967-5FC9-4F8C-B16A-DCA666C734F8Q48754351-BC08D302-3FBC-432A-BDA8-12AEDC7DCEA5
P2860
ANCA and associated diseases: immunodiagnostic and pathogenetic aspects.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
ANCA and associated diseases: immunodiagnostic and pathogenetic aspects.
@en
type
label
ANCA and associated diseases: immunodiagnostic and pathogenetic aspects.
@en
prefLabel
ANCA and associated diseases: immunodiagnostic and pathogenetic aspects.
@en
P2093
P2860
P1476
ANCA and associated diseases: immunodiagnostic and pathogenetic aspects.
@en
P2093
P2860
P356
10.1111/J.1365-2249.1993.TB03345.X
P577
1993-01-01T00:00:00Z